We believe in the power of partnerships. Through partnerships and strategic alliances we can find safe and effective therapies for some of the most debilitating diseases. Leveraging our library of novel new class of nanoparticles and innovative proprietary platform technology we are developing first in class therapies for central nervous system diseases and disorders by delivering next generation therapies.

Scientist on Computer

New Project

SMDG is a partner in the newly EU funded project DIRNANO.



We are partnering with researchers from across the world to find safe and effective therapies for debilitating diseases.



Our approach is different. We have designed and optimized an effective and versatile delivery platform technology along with a library of new class of nanoparticles. We have also focused on designing the next generation therapeutics expanding our discovery Programmes.

If you are interested in partnering with us to deliver the next generation of 21st century therapies, contact us today.

Ongoing Collaborations

We have established ongoing partnerships with renowned experts at some of

the leading academic institutions and organisations in the world, 

including Newcastle University, UK; University of Padova, Italy; University of Milano-Bicocca, Italy;

and CyberSym Technologies, USA.